Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices

Journal of Heart and Lung Transplantation

Volumn 33, Issue 1, 2014, Pages 80-87

  Birschmann, Ingvild ^a   Dittrich, Marcus ^b   Eller, Thomas ^c   Wiegmann, Bettina ^a   Reininger, Armin J ^d   Budde, Ulrich ^e   Strüber, Martin ^f  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c KLINIKUM MINDEN   (Germany)

^d BAXTER INNOVATIONS GMBH   (Austria)

^e ASKLEPIOS KLINIK ALTONA   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Anti platelet drugs; Aquired von Willebrand syndrome; Bleeding events; Left ventricular assist device; Platelet function; Thromboembolic event

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; ARACHIDONIC ACID; CLOPIDOGREL; COLLAGEN; DIPYRIDAMOLE; LACTATE DEHYDROGENASE; PROSTAGLANDIN E1; VASODILATOR STIMULATED PHOSPHOPROTEIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CARDIOMYOPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MALE; MIDDLE AGED; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK REDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOEMBOLISM; TREATMENT RESPONSE; VENTRICULAR ASSIST DEVICE; VON WILLEBRAND DISEASE;

ANTI-PLATELET DRUGS; AQUIRED VON WILLEBRAND SYNDROME; BLEEDING EVENTS; LEFT VENTRICULAR ASSIST DEVICE; PLATELET FUNCTION; THROMBOEMBOLIC EVENT;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMOLYSIS; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; THROMBOEMBOLISM; VENTRICULAR DYSFUNCTION, LEFT; VON WILLEBRAND DISEASES; YOUNG ADULT;

EID: 84892182928     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.11.010     Document Type: Article

References (35)

1. J.M. Schaffer, G.J. Arnaoutakis, and J.G. Allen et al. Bleeding complications and blood product utilization with left ventricular assist device implantation Ann Thorac Surg 91 2011 740 747
2. M. Struber, K. Sander, and J. Lahpor et al. HeartMate II left ventricular assist device; early European experience Eur J Cardiothorac Surg 34 2008 289 294
3. M.S. Slaughter, J.G. Rogers, and C.A. Milano et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
4. M. Strueber, G. O'Driscoll, P. Jansz, A. Khaghani, W.C. Levy, and G.M. Wieselthaler Multicenter evaluation of an intrapericardial left ventricular assist system J Am Coll Cardiol 57 2011 1375 1382
5. J. Klovaite, F. Gustafsson, S.A. Mortensen, K. Sander, and L.B. Nielsen Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II) J Am Coll Cardiol 53 2009 2162 2167
6. C. Heilmann, U. Geisen, and F. Beyersdorf et al. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart Thromb Haemost 103 2010 962 967
7. A.L. Meyer, D. Malehsa, and C. Bara et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circ Heart Fail 3 2010 675 681
8. A.S. Weyrich, and G.A. Zimmerman Platelets: signaling cells in the immune continuum Trends Immunol 25 2004 489 495
9. V.P. Addonizio Platelet function in cardiopulmonary bypass and artificial organs Hematol Oncol Clin North Am 4 1990 145 155
10. P.M. Eckman, and R. John Bleeding and thrombosis in patients with continuous-flow ventricular assist devices Circulation 125 2012 3038 3047
11. F. Michal, and G.V. Born Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma Nat New Biol 231 1971 220 222
12. S.K. Kundu, E.J. Heilmann, R. Sio, C. Garcia, R.M. Davidson, and R.A. Ostgaard Description of an in vitro platelet function analyzer - PFA-100 Semin Thromb Hemost 21 Suppl 2 1995 106 112
13. J. Geiger, L. Teichmann, and R. Grossmann et al. Monitoring of clopidogrel action: comparison of methods Clin Chem 51 2005 957 965
14. U. Budde, R. Schneppenheim, and J. Eikenboom et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD) J Thromb Haemost 6 2008 762 771
15. T. Hothorn, K. Hornik, M.A. van de Wiel, and A. Zeileis A Lego system for conditional inference Am Stat 60 2006 257 263
16. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
17. M. Cattaneo, C. Cerletti, and P. Harrison et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH J Thromb Haemost 11 2013 1183 1189
18. U. Geisen, C. Heilmann, and F. Beyersdorf et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease Eur J Cardiothorac Surg 33 2008 679 684
19. S. Crow, C. Milano, and L. Joyce et al. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients ASAIO J 56 2010 441 445
20. C.A. Siedlecki, B.J. Lestini, K.K. Kottke-Marchant, S.J. Eppell, D.L. Wilson, and R.E. Marchant Shear-dependent changes in the three-dimensional structure of human von Willebrand factor Blood 88 1996 2939 2950
21. I.W. Wang, K. Kottke-Marchant, R.L. Vargo, and P.M. McCarthy Hemostatic profiles of HeartMate ventricular assist device recipients ASAIO J 41 1995 M782 M787
22. A. Koster, M. Loebe, and R. Hansen et al. Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD Ann Thorac Surg 70 2000 533 537
23. F. Majeed, W.J. Kop, R.S. Poston, S. Kallam, and M.R. Mehra Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices Nat Clin Pract Cardiovasc Med 6 2009 147 157
24. R. John, S. Panch, and J. Hrabe et al. Activation of endothelial and coagulation systems in left ventricular assist device recipients Ann Thorac Surg 88 2009 1171 1179
25. A. Stepanenko, T. Krabatsch, and E. Hennig et al. Retrospective hemolysis comparison between patients with centrifugal biventricular assist and left ventricular assist devices ASAIO J 57 2011 382 387
26. M.N. Di Minno, R. Lupoli, N.M. Palmieri, A. Russolillo, A. Buonauro, and G. Di Minno Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update Thromb Res 129 2012 341 344
27. M. Karazniewicz-Lada, D. Danielak, and F. Glowka Genetic and non-genetic factors affecting the response to clopidogrel therapy Expert Opin Pharmacother 13 2012 663 683
28. G. Esposito Responsiveness to P2Y12 receptor inhibitors Curr Opin Cardiol 26 Suppl 1 2011 S31 S37
29. M.J. Price, and P.S. Teirstein Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers Am J Cardiol 102 2008 790 795
30. M.J. Price, J.S. Walder, and B.A. Baker et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial J Am Coll Cardiol 59 2012 2338 2343
31. R.F. Storey, K.P. Bliden, and R. Ecob et al. Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses J Thromb Haemost 9 2011 1730 1737
32. Y. Tamari, L. Aledort, and E. Puszkin et al. Functional changes in platelets during extracorporeal circulation Ann Thorac Surg 19 1975 639 647
33. K. Kawahito, J. Mohara, Y. Misawa, and K. Fuse Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins Artif Organs 21 1997 1105 1109
34. J.M. Siller-Matula, M. Francesconi, and C. Dechant et al. Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study Int J Cardiol 167 2013 2018 2023
35. P. Diehl, M. Aleker, and T. Helbing et al. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation Interact Cardiovasc Thorac Surg 11 2010 133 137